Naples Money Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Naples Money Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$6.31K	Buy	+6	New	+$6.68K	0.01%	217

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Naples Money Management's REGN Position: Q3 2024 in Review

Naples Money Management opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2024: 6 shares worth $6.31K. The stake represents 0.01% of the portfolio and ranks #217 among its holdings.

1,389 funds tracked by Wall St. Rank hold REGN as of Q3 2024.

Naples Money Management held 6 shares of Regeneron Pharmaceuticals worth $6.31K as of Q3 2024.
Regeneron Pharmaceuticals was a new Naples Money Management position in Q3 2024.
Regeneron Pharmaceuticals made up 0.01% of Naples Money Management's portfolio in Q3 2024, its #217 holding.
1,389 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2024.

Based on Naples Money Management's 13F filing for Q3 2024, filed 12 Nov 2024.